The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: The preliminary experience

Journal of Endourology

Volumn 27, Issue 7, 2013, Pages 820-825

  Mouraviev, Vladimir ^a   Verma, Sadhna ^a   Kalyanaraman, Balaji ^a   Zhai, Qihui J ^a   Gaitonde, Krishnanath ^a   Pugnale, Michael ^a   Donovan, James F ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ECHOGRAPH; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; IMAGING SYSTEM; LOW RISK POPULATION; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REAL TIME ECHOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; EQUIPMENT DESIGN; FEASIBILITY STUDIES; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84879981273     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0215     Document Type: Review

References (13)

1. Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic reso-nance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic reso-nance imaging. J Urol 2011;186:1281-1285.
2. Aydn H, Kzlgõz V, Tatar IG, et al. Detection of prostate cancer with magnetic resonance imaging: Optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings. J Comput Assist To-mogr 2012;36:30-45.
3. Zangos S, Melzer A, Eichler K, et al. MR-compatible assis-tance system for biopsy in a high-field-strength system: In-itial results in patients with suspicious prostate lesions. Radiology 2011;259:903-910.
4. Engelbrecht MR, Puech P, Colin P, et al. Multimodality magnetic resonance imaging of prostate cancer. J Endourol 2010;24:677-684.
5. Verma S, Rajesh A, Morales H, et al. Assessment of ag-gressiveness of prostate cancer: Correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011;196:374-381.
6. Villers A, Puech P, Mouton D, et al. Dynamic contrast en-hanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol 2006;176:2432-2437.
7. Fũtterer JJ, Verma S, Hambrock T, et al. High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies. Abdom Imaging 2012;37:892-896.
8. Franiel T, Stephan C, Erbersdobler A, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology 2011;259:162-172.
9. D'Amico AV, Moul J, Carroll PR, et al. Cancer-specific mortality after surgery or radiation for patients with clini-cally localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21:2163-2172.
10. Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies. J Urol 2001;166:402-410.
11. Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int 2007;99:1340-1344.
12. Mayes JM, Mouraviev V, Sun L, et al. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol 2011;29:166-170.
13. Verma S, Rajesh A, Fũtterer JJ, et al.: Prostate MRI and 3D MR spectroscopy: How we do it. AJR Am J Roentgenol 2010;194:1414-1426.